Cancer Genomic Testing Market, Global Outlook and Forecast 2024-2031

Report ID: 1068349 | Published Date: Jan 2025 | No. of Page: 64 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Cancer Genomic Testing Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Cancer Genomic Testing Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Cancer Genomic Testing Overall Market Size
    2.1 Global Cancer Genomic Testing Market Size: 2021 VS 2028
    2.2 Global Cancer Genomic Testing Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Cancer Genomic Testing Players in Global Market
    3.2 Top Global Cancer Genomic Testing Companies Ranked by Revenue
    3.3 Global Cancer Genomic Testing Revenue by Companies
    3.4 Top 3 and Top 5 Cancer Genomic Testing Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Cancer Genomic Testing Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Cancer Genomic Testing Players in Global Market
        3.6.1 List of Global Tier 1 Cancer Genomic Testing Companies
        3.6.2 List of Global Tier 2 and Tier 3 Cancer Genomic Testing Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Cancer Genomic Testing Market Size Markets, 2021 & 2028
        4.1.2 Breast Cancer Genomic Testing
        4.1.3 Lung Cancer Genomic Testing
        4.1.4 Blood Cancer Genomic Testing
        4.1.5 Liver Cancer Genomic Testing
        4.1.6 Stomach Cancer Genomic Testing
        4.1.7 Others
    4.2 By Type - Global Cancer Genomic Testing Revenue & Forecasts
        4.2.1 By Type - Global Cancer Genomic Testing Revenue, 2017-2022
        4.2.2 By Type - Global Cancer Genomic Testing Revenue, 2023-2028
        4.2.3 By Type - Global Cancer Genomic Testing Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Cancer Genomic Testing Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Diagnostic Laboratories
        5.1.5 Academic and Research Institutes
        5.1.6 Others
    5.2 By Application - Global Cancer Genomic Testing Revenue & Forecasts
        5.2.1 By Application - Global Cancer Genomic Testing Revenue, 2017-2022
        5.2.2 By Application - Global Cancer Genomic Testing Revenue, 2023-2028
        5.2.3 By Application - Global Cancer Genomic Testing Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Cancer Genomic Testing Market Size, 2021 & 2028
    6.2 By Region - Global Cancer Genomic Testing Revenue & Forecasts
        6.2.1 By Region - Global Cancer Genomic Testing Revenue, 2017-2022
        6.2.2 By Region - Global Cancer Genomic Testing Revenue, 2023-2028
        6.2.3 By Region - Global Cancer Genomic Testing Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Cancer Genomic Testing Revenue, 2017-2028
        6.3.2 US Cancer Genomic Testing Market Size, 2017-2028
        6.3.3 Canada Cancer Genomic Testing Market Size, 2017-2028
        6.3.4 Mexico Cancer Genomic Testing Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Cancer Genomic Testing Revenue, 2017-2028
        6.4.2 Germany Cancer Genomic Testing Market Size, 2017-2028
        6.4.3 France Cancer Genomic Testing Market Size, 2017-2028
        6.4.4 U.K. Cancer Genomic Testing Market Size, 2017-2028
        6.4.5 Italy Cancer Genomic Testing Market Size, 2017-2028
        6.4.6 Russia Cancer Genomic Testing Market Size, 2017-2028
        6.4.7 Nordic Countries Cancer Genomic Testing Market Size, 2017-2028
        6.4.8 Benelux Cancer Genomic Testing Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Cancer Genomic Testing Revenue, 2017-2028
        6.5.2 China Cancer Genomic Testing Market Size, 2017-2028
        6.5.3 Japan Cancer Genomic Testing Market Size, 2017-2028
        6.5.4 South Korea Cancer Genomic Testing Market Size, 2017-2028
        6.5.5 Southeast Asia Cancer Genomic Testing Market Size, 2017-2028
        6.5.6 India Cancer Genomic Testing Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Cancer Genomic Testing Revenue, 2017-2028
        6.6.2 Brazil Cancer Genomic Testing Market Size, 2017-2028
        6.6.3 Argentina Cancer Genomic Testing Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Cancer Genomic Testing Revenue, 2017-2028
        6.7.2 Turkey Cancer Genomic Testing Market Size, 2017-2028
        6.7.3 Israel Cancer Genomic Testing Market Size, 2017-2028
        6.7.4 Saudi Arabia Cancer Genomic Testing Market Size, 2017-2028
        6.7.5 UAE Cancer Genomic Testing Market Size, 2017-2028
7 Players Profiles
    7.1 Myriad Genetics
        7.1.1 Myriad Genetics Corporate Summary
        7.1.2 Myriad Genetics Business Overview
        7.1.3 Myriad Genetics Cancer Genomic Testing Major Product Offerings
        7.1.4 Myriad Genetics Cancer Genomic Testing Revenue in Global Market (2017-2022)
        7.1.5 Myriad Genetics Key News
    7.2 Centogene AG
        7.2.1 Centogene AG Corporate Summary
        7.2.2 Centogene AG Business Overview
        7.2.3 Centogene AG Cancer Genomic Testing Major Product Offerings
        7.2.4 Centogene AG Cancer Genomic Testing Revenue in Global Market (2017-2022)
        7.2.5 Centogene AG Key News
    7.3 Color Genomics
        7.3.1 Color Genomics Corporate Summary
        7.3.2 Color Genomics Business Overview
        7.3.3 Color Genomics Cancer Genomic Testing Major Product Offerings
        7.3.4 Color Genomics Cancer Genomic Testing Revenue in Global Market (2017-2022)
        7.3.5 Color Genomics Key News
    7.4 Quest Diagnostics
        7.4.1 Quest Diagnostics Corporate Summary
        7.4.2 Quest Diagnostics Business Overview
        7.4.3 Quest Diagnostics Cancer Genomic Testing Major Product Offerings
        7.4.4 Quest Diagnostics Cancer Genomic Testing Revenue in Global Market (2017-2022)
        7.4.5 Quest Diagnostics Key News
    7.5 23andMe Inc.
        7.5.1 23andMe Inc. Corporate Summary
        7.5.2 23andMe Inc. Business Overview
        7.5.3 23andMe Inc. Cancer Genomic Testing Major Product Offerings
        7.5.4 23andMe Inc. Cancer Genomic Testing Revenue in Global Market (2017-2022)
        7.5.5 23andMe Inc. Key News
    7.6 Gene By Gene Ltd.
        7.6.1 Gene By Gene Ltd. Corporate Summary
        7.6.2 Gene By Gene Ltd. Business Overview
        7.6.3 Gene By Gene Ltd. Cancer Genomic Testing Major Product Offerings
        7.6.4 Gene By Gene Ltd. Cancer Genomic Testing Revenue in Global Market (2017-2022)
        7.6.5 Gene By Gene Ltd. Key News
    7.7 LabCorp
        7.7.1 LabCorp Corporate Summary
        7.7.2 LabCorp Business Overview
        7.7.3 LabCorp Cancer Genomic Testing Major Product Offerings
        7.7.4 LabCorp Cancer Genomic Testing Revenue in Global Market (2017-2022)
        7.7.5 LabCorp Key News
    7.8 Positive Bioscience
        7.8.1 Positive Bioscience Corporate Summary
        7.8.2 Positive Bioscience Business Overview
        7.8.3 Positive Bioscience Cancer Genomic Testing Major Product Offerings
        7.8.4 Positive Bioscience Cancer Genomic Testing Revenue in Global Market (2017-2022)
        7.8.5 Positive Bioscience Key News
    7.9 Bio-Rad Laboratories
        7.9.1 Bio-Rad Laboratories Corporate Summary
        7.9.2 Bio-Rad Laboratories Business Overview
        7.9.3 Bio-Rad Laboratories Cancer Genomic Testing Major Product Offerings
        7.9.4 Bio-Rad Laboratories Cancer Genomic Testing Revenue in Global Market (2017-2022)
        7.9.5 Bio-Rad Laboratories Key News
    7.10 Illumina, Inc.
        7.10.1 Illumina, Inc. Corporate Summary
        7.10.2 Illumina, Inc. Business Overview
        7.10.3 Illumina, Inc. Cancer Genomic Testing Major Product Offerings
        7.10.4 Illumina, Inc. Cancer Genomic Testing Revenue in Global Market (2017-2022)
        7.10.5 Illumina, Inc. Key News
    7.11 Agilent Technologies
        7.11.1 Agilent Technologies Corporate Summary
        7.11.2 Agilent Technologies Business Overview
        7.11.3 Agilent Technologies Cancer Genomic Testing Major Product Offerings
        7.11.4 Agilent Technologies Cancer Genomic Testing Revenue in Global Market (2017-2022)
        7.11.5 Agilent Technologies Key News
    7.12 Thermo Fisher Scientific
        7.12.1 Thermo Fisher Scientific Corporate Summary
        7.12.2 Thermo Fisher Scientific Business Overview
        7.12.3 Thermo Fisher Scientific Cancer Genomic Testing Major Product Offerings
        7.12.4 Thermo Fisher Scientific Cancer Genomic Testing Revenue in Global Market (2017-2022)
        7.12.5 Thermo Fisher Scientific Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Cancer Genomic Testing Market Opportunities & Trends in Global Market
    Table 2. Cancer Genomic Testing Market Drivers in Global Market
    Table 3. Cancer Genomic Testing Market Restraints in Global Market
    Table 4. Key Players of Cancer Genomic Testing in Global Market
    Table 5. Top Cancer Genomic Testing Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Cancer Genomic Testing Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Cancer Genomic Testing Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Cancer Genomic Testing Product Type
    Table 9. List of Global Tier 1 Cancer Genomic Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Cancer Genomic Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Cancer Genomic Testing Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Cancer Genomic Testing Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Cancer Genomic Testing Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Cancer Genomic Testing Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Cancer Genomic Testing Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Cancer Genomic Testing Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Cancer Genomic Testing Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Cancer Genomic Testing Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Cancer Genomic Testing Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Cancer Genomic Testing Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Cancer Genomic Testing Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Cancer Genomic Testing Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Cancer Genomic Testing Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Cancer Genomic Testing Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Cancer Genomic Testing Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Cancer Genomic Testing Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Cancer Genomic Testing Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Cancer Genomic Testing Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Cancer Genomic Testing Revenue, (US$, Mn), 2023-2028
    Table 30. Myriad Genetics Corporate Summary
    Table 31. Myriad Genetics Cancer Genomic Testing Product Offerings
    Table 32. Myriad Genetics Cancer Genomic Testing Revenue (US$, Mn), (2017-2022)
    Table 33. Centogene AG Corporate Summary
    Table 34. Centogene AG Cancer Genomic Testing Product Offerings
    Table 35. Centogene AG Cancer Genomic Testing Revenue (US$, Mn), (2017-2022)
    Table 36. Color Genomics Corporate Summary
    Table 37. Color Genomics Cancer Genomic Testing Product Offerings
    Table 38. Color Genomics Cancer Genomic Testing Revenue (US$, Mn), (2017-2022)
    Table 39. Quest Diagnostics Corporate Summary
    Table 40. Quest Diagnostics Cancer Genomic Testing Product Offerings
    Table 41. Quest Diagnostics Cancer Genomic Testing Revenue (US$, Mn), (2017-2022)
    Table 42. 23andMe Inc. Corporate Summary
    Table 43. 23andMe Inc. Cancer Genomic Testing Product Offerings
    Table 44. 23andMe Inc. Cancer Genomic Testing Revenue (US$, Mn), (2017-2022)
    Table 45. Gene By Gene Ltd. Corporate Summary
    Table 46. Gene By Gene Ltd. Cancer Genomic Testing Product Offerings
    Table 47. Gene By Gene Ltd. Cancer Genomic Testing Revenue (US$, Mn), (2017-2022)
    Table 48. LabCorp Corporate Summary
    Table 49. LabCorp Cancer Genomic Testing Product Offerings
    Table 50. LabCorp Cancer Genomic Testing Revenue (US$, Mn), (2017-2022)
    Table 51. Positive Bioscience Corporate Summary
    Table 52. Positive Bioscience Cancer Genomic Testing Product Offerings
    Table 53. Positive Bioscience Cancer Genomic Testing Revenue (US$, Mn), (2017-2022)
    Table 54. Bio-Rad Laboratories Corporate Summary
    Table 55. Bio-Rad Laboratories Cancer Genomic Testing Product Offerings
    Table 56. Bio-Rad Laboratories Cancer Genomic Testing Revenue (US$, Mn), (2017-2022)
    Table 57. Illumina, Inc. Corporate Summary
    Table 58. Illumina, Inc. Cancer Genomic Testing Product Offerings
    Table 59. Illumina, Inc. Cancer Genomic Testing Revenue (US$, Mn), (2017-2022)
    Table 60. Agilent Technologies Corporate Summary
    Table 61. Agilent Technologies Cancer Genomic Testing Product Offerings
    Table 62. Agilent Technologies Cancer Genomic Testing Revenue (US$, Mn), (2017-2022)
    Table 63. Thermo Fisher Scientific Corporate Summary
    Table 64. Thermo Fisher Scientific Cancer Genomic Testing Product Offerings
    Table 65. Thermo Fisher Scientific Cancer Genomic Testing Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Cancer Genomic Testing Segment by Type in 2021
    Figure 2. Cancer Genomic Testing Segment by Application in 2021
    Figure 3. Global Cancer Genomic Testing Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Cancer Genomic Testing Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Cancer Genomic Testing Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Cancer Genomic Testing Revenue in 2021
    Figure 8. By Type - Global Cancer Genomic Testing Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Cancer Genomic Testing Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Cancer Genomic Testing Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Cancer Genomic Testing Revenue Market Share, 2017-2028
    Figure 12. US Cancer Genomic Testing Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Cancer Genomic Testing Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Cancer Genomic Testing Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Cancer Genomic Testing Revenue Market Share, 2017-2028
    Figure 16. Germany Cancer Genomic Testing Revenue, (US$, Mn), 2017-2028
    Figure 17. France Cancer Genomic Testing Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Cancer Genomic Testing Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Cancer Genomic Testing Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Cancer Genomic Testing Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Cancer Genomic Testing Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Cancer Genomic Testing Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Cancer Genomic Testing Revenue Market Share, 2017-2028
    Figure 24. China Cancer Genomic Testing Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Cancer Genomic Testing Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Cancer Genomic Testing Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Cancer Genomic Testing Revenue, (US$, Mn), 2017-2028
    Figure 28. India Cancer Genomic Testing Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Cancer Genomic Testing Revenue Market Share, 2017-2028
    Figure 30. Brazil Cancer Genomic Testing Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Cancer Genomic Testing Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Cancer Genomic Testing Revenue Market Share, 2017-2028
    Figure 33. Turkey Cancer Genomic Testing Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Cancer Genomic Testing Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Cancer Genomic Testing Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Cancer Genomic Testing Revenue, (US$, Mn), 2017-2028
    Figure 37. Myriad Genetics Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Centogene AG Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Color Genomics Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Quest Diagnostics Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. 23andMe Inc. Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Gene By Gene Ltd. Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. LabCorp Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Positive Bioscience Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Bio-Rad Laboratories Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Illumina, Inc. Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Agilent Technologies Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Thermo Fisher Scientific Cancer Genomic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
64
Frequently Asked Questions
Cancer Genomic Testing Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cancer Genomic Testing Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cancer Genomic Testing Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports